Andrew J. McLaren
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Andrew J. McLaren has a total of 13 co-authors. Here are the top co-authors by number of shared publications:
A D Northeast
Department of Surgery, Wycombe Hospital, High Wycombe HP11 2TT, UK
1 shared publication- Charles G. Mullighan
St Jude Children's Research Hospital, Memphis, Tennessee, United States
1 shared publication Dwr Gray
Nuffield Department of Surgery, John Radcliffe Hospital
1 shared publicationKen I. Welsh
1 shared publicationKi Welsh
Oxford Transplant Centre, Churchill Hospital, Oxford, UK
1 shared publicationN Riazuddin
Department of Surgery, Wycombe Hospital, High Wycombe HP11 2TT, UK
1 shared publication
Latest Publications
- Open Access
- 1 June 2001
- Published by SAGE Publications in Journal of the Royal Society of Medicine
- Vol. 94 (6) , 292-293
Mondor Meets Trendelenburg: Penile Vein Thrombosis after Varicose Vein Surgery
- 1 June 2001
- Published by SAGE Publications in Journal of the Royal Society of Medicine
- Vol. 94 (6) , 292-293
Open AccessMondor Meets Trendelenburg: Penile Vein Thrombosis after Varicose Vein Surgery
- 1 May 1999
- Published by Elsevier in Kidney International
- Vol. 55 (5) , 1977-1982
Adhesion molecule polymorphisms in chronic renal allograft failure
- 1 May 1999
- Published by Elsevier in Kidney International
- Vol. 55 (5) , 1977-1982
Adhesion molecule polymorphisms in chronic renal allograft failure
- 1 March 1999
- Published by Wiley in Clinical Transplantation
- Vol. 13 (3) , 266-272
Delayed graft function: risk factors and the relative effects of early function and acute rejection on long‐term survival in cadaveric renal transplantation
Delayed graft function (DGF) and acute rejection have both been associated with reduced renal allograft survival. In some studies, they have been shown to have an interactive effect. We studied the risk factors for DGF and the relative impact of DGF and rejection on both short‐ and long‐term survival in recipients of cadaveric renal transplants.Data from the Oxford Transplant Centre Database were assessed on 710 cadaver allografts over a 10‐yr period, during which time all recipients received cyclosporin‐based immunosuppressive protocols. The interaction between DGF and acute rejection was examined using logistic and Cox multivariate regression.Long cold ischaemia time (CIT), sensitisation and older donor age were found to be independent predictors of DGF. The occurrence of DGF resulted in a reduced 5‐yr survival (56 vs. 75%). However, the effect of DGF was confined to the first year post‐transplant, as there was no significant difference in survival, as measured by half‐life (t1/2) of grafts functioning at 1 yr, with DGF alone and a group with good early function (t1/2=21.3 vs. 20.0 yr). There was no increase in acute rejection in grafts with DGF. However, the combination of DGF and acute rejection resulted in the worst short‐term graft survival (68% at 1 yr, compared to 92.3% in those grafts with no DGF or acute rejection) and this continued over the long term (t1/2=10.5 yr).These data suggest that early function is critical to the success of renal transplantation. The effects of DGF are limited to the first year post‐transplant. Long‐term graft survival may be improved by efforts to limit CITs, particularly for grafts from older donors and sensitised recipients.
- 1 March 1999
- Published by Wiley in Clinical Transplantation
- Vol. 13 (3) , 266-272
Delayed graft function: risk factors and the relative effects of early function and acute rejection on long‐term survival in cadaveric renal transplantation
Delayed graft function (DGF) and acute rejection have both been associated with reduced renal allograft survival. In some studies, they have been shown to have an interactive effect. We studied the risk factors for DGF and the relative impact of DGF and rejection on both short‐ and long‐term survival in recipients of cadaveric renal transplants.Data from the Oxford Transplant Centre Database were assessed on 710 cadaver allografts over a 10‐yr period, during which time all recipients received cyclosporin‐based immunosuppressive protocols. The interaction between DGF and acute rejection was examined using logistic and Cox multivariate regression.Long cold ischaemia time (CIT), sensitisation and older donor age were found to be independent predictors of DGF. The occurrence of DGF resulted in a reduced 5‐yr survival (56 vs. 75%). However, the effect of DGF was confined to the first year post‐transplant, as there was no significant difference in survival, as measured by half‐life (t1/2) of grafts functioning at 1 yr, with DGF alone and a group with good early function (t1/2=21.3 vs. 20.0 yr). There was no increase in acute rejection in grafts with DGF. However, the combination of DGF and acute rejection resulted in the worst short‐term graft survival (68% at 1 yr, compared to 92.3% in those grafts with no DGF or acute rejection) and this continued over the long term (t1/2=10.5 yr).These data suggest that early function is critical to the success of renal transplantation. The effects of DGF are limited to the first year post‐transplant. Long‐term graft survival may be improved by efforts to limit CITs, particularly for grafts from older donors and sensitised recipients.